Daniel Bengtsson

Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide

Daniel Bengtsson, Henrik Daa Schrøder, Marianne Andersen et al. · The Journal of Clinical Endocrinology & Metabolism · 2015 · 189 citations · Full text

Medicine, Oncology, Pharmacology +15

Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations

Olivera Casar‐Borota, Henning B. Boldt, Britt Edén Engström et al. · The Journal of Clinical Endocrinology & Metabolism · 2020 · 102 citations · Full text

Medicine, Endocrinology, Molecular Genetics +17

Corticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS Cohort

Daniel Bengtsson, Patrick Joost, Christos Aravidis et al. · The Journal of Clinical Endocrinology & Metabolism · 2017 · 78 citations · Full text

Medicine, Endocrinology, Oncology +17

Fluorescence spectra provide information on the depth of fluorescent lesions in tissue

Johannes Swartling, Jenny Svensson, Daniel Bengtsson et al. · Applied Optics · 2005 · 71 citations · Full text

Engineering, Biomedical Engineering, Biophysics +13

Atheroprotective Effects of Alum Are Associated With Capture of Oxidized LDL Antigens and Activation of Regulatory T Cells

Maria Wigren, Daniel Bengtsson, Pontus Dunér et al. · Circulation Research · 2009 · 61 citations

Life Sciences, Immunology, Pathobiology +16